Académique Documents
Professionnel Documents
Culture Documents
Eko Butar-butar
Pathological abnormalities; or
Children
No preformed stores
IDA in CKD
IN CKD
Blood loss
Risk of blood loss due to platelet dysfunction.
uremic milieu
The uremic milieu is a term that is overused
in attempts to explain the multiple organ dysfunction
of chronic kidney disease.
CKD ND
Hb > 10g/dL - ESA not to be initiated
CKD 5D
ESA therapy should be initiated when the
Hb is between 9.010.0 g/dL
ESA
Therapy TARGET HB LEVEL:
Objective of initial ESA therapy is a rate of increase in (Hb) of
1.0 to 2.0 g/dl (10 to 20 g/l) per month
Rise in Hb of > 2.0 g/dl (20 g/l) over a 4-week period should
be avoided
Hypertension,-30%
Hypertensive encephalopathy
Vascular access failure
Increase in pre dialysis CKP ,and potassium
Increases risk of stroke in DM type 2.
Red cell transfusion to treat anemia in CKD
References
Emed
Davidson
Kumar and clark
Harrisons
Anaemia management in chronic kidney disease
NICE clinical guideline 39
Thank you